
Azisan40 mg
Renata Limited
Azilsartan Medoxomil is an angiotensin II receptor blocker (ARB) that is FDA-approved for the following use: Hypertension (established/approved use): Treatment of high blood pressure in adults and more.
Azilsartan Medoxomil is an angiotensin II receptor blocker (ARB) that is FDA-approved for the following use:
Azilsartan Medoxomil is not approved for use in children, and it is not indicated for heart failure or diabetic nephropathy, although other drugs in the ARB class are used for those conditions.
| Indication | Recommended Dose |
|---|---|
| Hypertension - standard starting dose | 80 mg orally once daily |
| Patients with intravascular volume depletion (e.g., on diuretics) | Start at 40 mg once daily |
| Maximum dose | 80 mg once daily |
Safety and efficacy of Azilsartan Medoxomil have not been established in patients under 18 years of age; it is not recommended for pediatric use.
No initial dosage adjustment of Azilsartan Medoxomil is required for mild-to-moderate renal impairment; monitor renal function periodically. Use in patients with severe renal impairment or on dialysis has not been well studied and requires caution.
Limited data are available in hepatic impairment; use Azilsartan Medoxomil with caution and monitor blood pressure in patients with moderate to severe hepatic impairment.
Azilsartan Medoxomil tablets may be taken with or without food, at approximately the same time each day, and may be combined with other antihypertensive drugs if additional blood pressure control is needed.
Most patients tolerate Azilsartan Medoxomil well. Reported side effects include:
Azilsartan Medoxomil is associated with a low incidence of dry cough compared with ACE inhibitors.
Azilsartan Medoxomil is contraindicated in the following situations:
Disclaimer
The information provided is accurate to the best of our knowledge, but it does not replace professional medical advice. We cannot guarantee its completeness or accuracy, and the absence of specific information about a drug should not be taken as an endorsement. We are not responsible for any consequences arising from this information, so please consult a healthcare professional for any concerns or questions.